Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 24 results:
Author Title Type [ Year] Filters: Keyword is Cholesterol, HDL [Clear All Filters]
(2019).
The ABCB1 2677G>T/A polymorphism is associated with baseline blood HDL-cholesterol levels in newly diagnosed hyperlipidemic patients..
Hellenic J Cardiol. 59(2), 122-126.
(2018). Prognostic significance of major lipids in patients with acute ischemic stroke..
Metab Brain Dis. 32(2), 395-400.
(2017). Impaired metabolic profile is a predictor of capillary rarefaction in a population of hypertensive and normotensive individuals..
J Am Soc Hypertens. 10(8), 640-6.
(2016). Unresolved issues in lipid-lowering treatment..
Panminerva Med. 58(2), 191-5.
(2016). Arterial Stiffness and Emerging Biomarkers: Still a Long Journey to Go..
Angiology. 66(10), 901-3.
(2015). High-intensity statin therapy and regression of coronary atherosclerosis in patients with diabetes mellitus..
J Diabetes Complications. 29(1), 142-5.
(2015). Achieving lipid targets in primary care settings..
Curr Med Res Opin. 30(10), 1971-4.
(2014). Sex-specific differences in cardiovascular risk factors and blood pressure control in hypertensive patients..
J Clin Hypertens (Greenwich). 16(4), 309-12.
(2014). Should raising high-density lipoprotein cholesterol be a matter of debate?.
J Cardiovasc Med (Hagerstown). 13(4), 254-9.
(2012). Apelin levels in normal pregnancy..
Clin Endocrinol (Oxf). 75(3), 367-71.
(2011). The DEFINE study: a bright future for CETP inhibitors?.
Expert Opin Investig Drugs. 20(3), 311-4.
(2011). Oxidized low-density lipoprotein and adiponectin levels in pregnancy..
Gynecol Endocrinol. 27(12), 1070-3.
(2011). Beneficial effects of oral magnesium supplementation on insulin sensitivity and serum lipid profile..
Med Sci Monit. 16(6), CR307-312.
(2010). Rising serum 25-hydroxy-vitamin D levels after weight loss in obese women correlate with improvement in insulin resistance..
J Clin Endocrinol Metab. 95(9), 4251-7.
(2010). Clinical review: The pathogenetic role of cortisol in the metabolic syndrome: a hypothesis..
J Clin Endocrinol Metab. 94(8), 2692-701.
(2009). JUPITER: major implications for vascular risk assessment..
Curr Med Res Opin. 25(1), 133-7.
(2009). Cholesteryl ester transfer protein inhibition and HDL increase: has the dream ended?.
Expert Opin Investig Drugs. 17(4), 445-9.
(2008). High density lipoprotein cholesterol and statin trials..
Curr Med Chem. 15(22), 2265-70.
(2008). Association of drinking pattern and alcohol beverage type with the prevalence of metabolic syndrome, diabetes, CHD, stroke, and peripheral arterial disease in a Mediterranean cohort..
Angiology. 58(6), 689-97.
(2007). Atorvastatin decreases triacylglycerol-associated risk of vascular events in coronary heart disease patients..
Lipids. 42(11), 999-1009.
(2007). Identifying and attaining LDL-C goals: mission accomplished? Next target: new therapeutic options to raise HDL-C levels..
Curr Drug Targets. 8(3), 483-8.
(2007). Statins and regression of coronary atherosclerosis..
JAMA. 297(20), 2197; author reply 2197.
(2007). Dyslipidaemia, hypercoagulability and the metabolic syndrome..
Curr Vasc Pharmacol. 4(3), 175-83.
(2006).